Monopar Therapeutics MNPR
$ 26.12
9.79%
Quarterly report 2024-Q3
added 11-08-2024
Monopar Therapeutics EV/EBITDA Ratio 2011-2024 | MNPR
Annual EV/EBITDA Ratio Monopar Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-2.05 | -11.6 | -33.2 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-2.05 | -33.2 | -15.6 |